2019 ACOG实践简报:妊娠与心脏病(No.212)

2019-04-25 美国妇产科医师学会 Obstet Gynecol. 2019 Mar;133(5):e320-e356.

2019年,美国妇产科医师学会(ACOG)发布了妊娠与心脏病指南,母源性心脏病已成为威胁母亲安全及女性长期心血管健康的主要疾病。本文的主要目的是介绍心脏病在孕妇和产后妇女中的流行情况和影响,提供产前和产后早期危险因素的识别和管理指导。

中文标题:

2019 ACOG实践简报:妊娠与心脏病(No.212)

英文标题:

ACOG Practice Bulletin No. 212: Pregnancy and Heart Disease.

发布机构:

美国妇产科医师学会

发布日期:

2019-04-25

简要介绍:

2019年,美国妇产科医师学会(ACOG)发布了妊娠与心脏病指南,母源性心脏病已成为威胁母亲安全及女性长期心血管健康的主要疾病。本文的主要目的是介绍心脏病在孕妇和产后妇女中的流行情况和影响,提供产前和产后早期危险因素的识别和管理指导。 

拓展指南:妊娠相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 ACOG实践简报:妊娠与心脏病(No.212))] GetToolGuiderByIdResponse(projectId=1, id=7371a1c001e3731e, title=2019 ACOG实践简报:妊娠与心脏病(No.212), enTitle=ACOG Practice Bulletin No. 212: Pregnancy and Heart Disease., guiderFrom=Obstet Gynecol. 2019 Mar;133(5):e320-e356., authorId=null, author=, summary=2019年,美国妇产科医师学会(ACOG)发布了妊娠与心脏病指南,母源性心脏病已成为威胁母亲安全及女性长期心血管健康的主要疾病。本文的主要目的是介绍心脏病在孕妇和产后妇女中的流行情况和影响,提供产前和产后早期危险因素的识别和管理指导。 , cover=, journalId=null, articlesId=null, associationId=357, associationName=美国妇产科医师学会, associationIntro=美国妇产科医师学会(ACOG),前身为美国妇产科学院,是一个美国妇产科妇科专业医生的专业协会。ACOG拥有超过55000名会员,其中90% 的会员是在美国经执业认证的妇产科医生。Obstetrics & Gynecology是ACOG的官方刊物。通常被称为&ldquo;绿色杂志&rdquo;。 American College of Obstetricians and Gynecologists, copyright=0, guiderPublishedTime=Thu Apr 25 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年,美国妇产科医师学会(ACOG)发布了妊娠与心脏病指南,母源性心脏病已成为威胁母亲安全及女性长期心血管健康的主要疾病。本文的主要目的是介绍心脏病在孕妇和产后妇女中的流行情况和影响,提供产前和产后早期危险因素的识别和管理指导。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>妊娠</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=5dbdc1c001e33a74" title="2019 USPSTF建议声明:儿童和妊娠期女性血铅水平升高的筛查" target=_blank>2019 USPSTF建议声明:儿童和妊娠期女性血铅水平升高的筛查</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=ba1bb1c001e26678" title="高龄妇女妊娠前、妊娠期及分娩期管理专家共识(2019)" target=_blank>高龄妇女妊娠前、妊娠期及分娩期管理专家共识(2019)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=44da61c001e261b3" title="2019 AHCDO共识声明:妊娠期遗传性出血性疾病的管理(更新)" target=_blank>2019 AHCDO共识声明:妊娠期遗传性出血性疾病的管理(更新)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=daab91c001e201dd" title="2018 BHIVA指南:妊娠和产后HIV的管理" target=_blank>2018 BHIVA指南:妊娠和产后HIV的管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=f130e1c001e1a7ff" title="2019 ACOG实践简报:妊娠期血小板减少症(No.207)" target=_blank>2019 ACOG实践简报:妊娠期血小板减少症(No.207)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E5%A6%8A%E5%A8%A0" target=_blank>有关妊娠更多指南</a></ul>, tagList=[TagDto(tagId=2457, tagName=妊娠), TagDto(tagId=577, tagName=心脏病)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5578, appHits=272, showAppHits=0, pcHits=3664, showPcHits=2594, likes=67, shares=21, comments=3, approvalStatus=1, publishedTime=Fri May 17 00:25:39 CST 2019, publishedTimeString=2019-04-25, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri May 17 00:25:39 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 03:59:34 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 ACOG实践简报:妊娠与心脏病(No.212))])
2019 ACOG实践简报:妊娠与心脏病(No.212)
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1057204, encodeId=9eb7105e20467, content=谢谢 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:40:16 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057197, encodeId=3605105e1973b, content=谢谢 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:39:25 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366343, encodeId=91b53663439c, content=求翻译软件, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcea2205128, createdName=120c2b82m70暂无昵称, createdTime=Fri May 17 10:59:26 CST 2019, time=2019-05-17, status=1, ipAttribution=)]
    2021-10-03 H8888888

    谢谢 学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1057204, encodeId=9eb7105e20467, content=谢谢 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:40:16 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057197, encodeId=3605105e1973b, content=谢谢 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:39:25 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366343, encodeId=91b53663439c, content=求翻译软件, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcea2205128, createdName=120c2b82m70暂无昵称, createdTime=Fri May 17 10:59:26 CST 2019, time=2019-05-17, status=1, ipAttribution=)]
    2021-10-03 H8888888

    谢谢 学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1057204, encodeId=9eb7105e20467, content=谢谢 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:40:16 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057197, encodeId=3605105e1973b, content=谢谢 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Sun Oct 03 17:39:25 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366343, encodeId=91b53663439c, content=求翻译软件, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcea2205128, createdName=120c2b82m70暂无昵称, createdTime=Fri May 17 10:59:26 CST 2019, time=2019-05-17, status=1, ipAttribution=)]
    2019-05-17 120c2b82m70暂无昵称

    求翻译软件

    0